Aryastha Life Sciences, a leading Contract Research and Development Organization in healthcare, has achieved a major milestone by successfully concluding its Series A funding with significant backing from Vessella Group, a prominent investor in India. Tempus Law Associates and Cyril Amarchand Mangaldas structured the business legally. While specific Series A terms remain undisclosed, Aryastha's partnership with Vessella promises innovation and quality healthcare services worl